Acasti Pharma Inc. (CVE:ACST – Get Free Report)’s share price shot up 1.8% during trading on Thursday . The company traded as high as C$0.58 and last traded at C$0.58. 2,450 shares traded hands during trading, a decline of 63% from the average session volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Stock Performance
The stock has a 50 day simple moving average of C$0.58 and a 200 day simple moving average of C$0.58. The stock has a market cap of C$25.87 million, a P/E ratio of -1.07 and a beta of 1.22. The company has a current ratio of 9.74, a quick ratio of 9.41 and a debt-to-equity ratio of 0.52.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Featured Stories
- Five stocks we like better than Acasti Pharma
- How to Read Stock Charts for Beginners
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Investing In Automotive Stocks
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- What is the Euro STOXX 50 Index?
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
